245 related articles for article (PubMed ID: 30579818)
1. Use of botulinum toxin in Parkinson's disease.
Jocson A; Lew M
Parkinsonism Relat Disord; 2019 Feb; 59():57-64. PubMed ID: 30579818
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
Sheffield JK; Jankovic J
Expert Rev Neurother; 2007 Jun; 7(6):637-47. PubMed ID: 17563247
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin in parkinsonism: The when, how, and which for botulinum toxin injections.
Cardoso F
Toxicon; 2018 Jun; 147():107-110. PubMed ID: 28837826
[TBL] [Abstract][Full Text] [Related]
4. Disease-oriented approach to botulinum toxin use.
Jankovic J
Toxicon; 2009 Oct; 54(5):614-23. PubMed ID: 19073203
[TBL] [Abstract][Full Text] [Related]
5. An update on the use of botulinum toxin therapy in Parkinson's disease.
Mills R; Bahroo L; Pagan F
Curr Neurol Neurosci Rep; 2015 Jan; 15(1):511. PubMed ID: 25407133
[TBL] [Abstract][Full Text] [Related]
6. Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal.
Jost WH
Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33503872
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin in the management of parkinsonian disorders.
Grippe T; Chen R
Toxicon; 2023 Aug; 232():107209. PubMed ID: 37429465
[TBL] [Abstract][Full Text] [Related]
8. Botulinum Toxin Therapy for Parkinson's Disease.
Wagle Shukla A; Malaty IA
Semin Neurol; 2017 Apr; 37(2):193-204. PubMed ID: 28511260
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review.
Mitchell SD; Sidiropoulos C
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33808714
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin treatment in parkinsonism.
Anandan C; Jankovic J
J Neurol Sci; 2024 Jan; 456():122810. PubMed ID: 38056063
[TBL] [Abstract][Full Text] [Related]
11. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
Ondo WG; Hunter C; Moore W
Neurology; 2004 Jan; 62(1):37-40. PubMed ID: 14718694
[TBL] [Abstract][Full Text] [Related]
12. [Digestive disorders in Parkinson's disease: dysphagia and sialorrhea].
González-Fernández J; Prieto-Albin R; Velasco-Palacios L; Jorge-Roldán S; Cubo-Delgado E
Rev Neurol; 2010 Feb; 50 Suppl 2():S51-4. PubMed ID: 20205142
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin in movement disorders.
Tater P; Pandey S
Neurol India; 2018; 66(Supplement):S79-S89. PubMed ID: 29503330
[TBL] [Abstract][Full Text] [Related]
14. Botulinum Toxin Therapy for Nonmotor Aspects of Parkinson's Disease.
Sławek J; Madaliński M
Int Rev Neurobiol; 2017; 134():1111-1142. PubMed ID: 28805566
[TBL] [Abstract][Full Text] [Related]
15. Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins.
Narayanaswami P; Geisbush T; Tarulli A; Raynor E; Gautam S; Tarsy D; Gronseth G
Parkinsonism Relat Disord; 2016 Sep; 30():73-7. PubMed ID: 27406786
[TBL] [Abstract][Full Text] [Related]
16. Botulinum Toxin Treatment of Motor Disorders in Parkinson Disease-A Systematic Review.
Jabbari B; Comtesse SM
Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828396
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P
J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630
[No Abstract] [Full Text] [Related]
18. Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism.
Bruno VA; Fox SH; Mancini D; Miyasaki JM
Can J Neurol Sci; 2016 Sep; 43(5):697-702. PubMed ID: 27514242
[TBL] [Abstract][Full Text] [Related]
19. An update on new and unique uses of botulinum toxin in movement disorders.
Jankovic J
Toxicon; 2018 Jun; 147():84-88. PubMed ID: 28888928
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and therapeutic recommendations in adult dystonia: a joint document by the Italian Society of Neurology, the Italian Academy for the Study of Parkinson's Disease and Movement Disorders, and the Italian Network on Botulinum Toxin.
Romano M; Bagnato S; Altavista MC; Avanzino L; Belvisi D; Bologna M; Bono F; Carecchio M; Castagna A; Ceravolo R; Conte A; Cosentino G; Eleopra R; Ercoli T; Esposito M; Fabbrini G; Ferrazzano G; Lalli S; Mascia MM; Osio M; Pellicciari R; Petrucci S; Valente EM; Valentino F; Zappia M; Zibetti M; Girlanda P; Tinazzi M; Defazio G; Berardelli A
Neurol Sci; 2022 Dec; 43(12):6929-6945. PubMed ID: 36190683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
